Taysha Gene Therapies
TSHA
NZ$4.47
Share price
0.75%
Change (1 day)
14.75%
Change (1 year)
Earnings for Taysha Gene Therapies (TSHA)
Earnings in 2025 (TTM): -NZ$0.15 Billion
According to Taysha Gene Therapies's latest financial reports the company's current earnings are NZ$7.22 Million. In 2024 the company made an earning of -NZ$0.15 Billion, an increase over its 2023 earnings that were of -NZ$0.19 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Taysha Gene Therapies from 2020 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -NZ$0.15 Billion | -2.49% |
| 2024 | -NZ$0.15 Billion | -19.96% |
| 2023 | -NZ$0.19 Billion | -33.06% |
| 2022 | -NZ$0.28 Billion | -4.51% |
| 2021 | -NZ$0.3 Billion | 190.82% |
| 2020 | -NZ$0.11 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -NZ$0.25 Billion | 68.99% | 🇺🇸 USA |